Since energy regulators approved the first recipient in June, about one loan has been announced per month. The most recent loan — a third for NRG — was announced on Nov. 20. Tom Fox / TNS AUSTIN — ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

Google announced Private AI Compute, a cloud-based platform that boosts your devices’ AI horsepower without sacrificing your data’s dignity. Campbell soup at risk of being "shut down" in Florida after ...

Brian Walshe’s wife Ana, fell victim to “sudden unexplained death,” before he panicked and got rid of her body — because he thought everyone would blame him, his lawyer told jurors. The irony, of ...

NuScale is making nuclear power relevant again. It's not the only company doing so, though. Its future is fuzzy simply because the sales-to-installation-to-operational time frame is so long, and it's ...

In-N-Out is expanding to Tennessee, with the first locations expected to open by the end of 2025. The chain's expansion is limited by the reach of its Texas warehouse, which can service Tennessee. CEO ...

In-N-Out Burger to open at least some restaurants by the end of 2025. In-N-Out Burger plans to start serving customers in Middle Tennessee by the end of 2025, though the company wasn't specific about ...

United Airlines sparked online buzz of a potential partnership with Southern California burger giant In-N-Out with an Instagram post over the weekend. The post featured a United plane flying over the ...

A jury in a suburban town south of Boston is set to hear the murder case against Brian Walshe in the death of his wife, Ana Walshe, nearly three years after her disappearance garnered national ...

Walshe, 50, is accused of killing his wife Ana, 39, sometime on or after New Year's Day in 2023, and hiding her remains, which have never been found Real estate executive Ana Walshe, 39, of Cohasset, ...

AI developers sell services on a usage-based pricing model, but they are often locked into rigid, long-term contracts for underlying computing resources. Many investors are worried this is a flawed ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...